PTC Therapeutics rises as UBS restarts coverage with buy rating
narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating.…
THE HELITRA EDIT
Tag: coverage
Heltra: Explore Life – Discover More – Live Better